Ocugen IncNASDAQ:OCGN
- LAST PRICE1.5900
- TODAY'S CHANGE (%)-0.0800 (-4.7904%)
- Bid / Lots1.6000/ 156
- Ask / Lots1.6100/ 99
- Open / Previous Close1.6700 / 1.6700
- Day Range
- 52 Week Range
- Volume4,735,691
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | OCGN |
|---|---|---|
| 09:32 ET | 214687 | 1.65 |
| 09:34 ET | 89821 | 1.62 |
| 09:36 ET | 40781 | 1.625 |
| 09:38 ET | 12117 | 1.6201 |
| 09:39 ET | 107111 | 1.611 |
| 09:41 ET | 16185 | 1.615 |
| 09:43 ET | 79599 | 1.6097 |
| 09:45 ET | 44956 | 1.62 |
| 09:48 ET | 19882 | 1.62 |
| 09:50 ET | 50480 | 1.62 |
| 09:52 ET | 31363 | 1.605 |
| 09:54 ET | 15148 | 1.6012 |
| 09:56 ET | 28164 | 1.605 |
| 09:57 ET | 28364 | 1.6099 |
| 09:59 ET | 15612 | 1.6 |
| 10:01 ET | 300599 | 1.57 |
| 10:03 ET | 63103 | 1.5601 |
| 10:06 ET | 123964 | 1.5798 |
| 10:08 ET | 33824 | 1.57 |
| 10:10 ET | 100030 | 1.57 |
| 10:12 ET | 35223 | 1.56 |
| 10:14 ET | 92658 | 1.565 |
| 10:15 ET | 8328 | 1.5685 |
| 10:17 ET | 29177 | 1.56 |
| 10:19 ET | 14364 | 1.565 |
| 10:21 ET | 114119 | 1.5552 |
| 10:24 ET | 43148 | 1.545 |
| 10:26 ET | 46007 | 1.564 |
| 10:28 ET | 44906 | 1.56 |
| 10:30 ET | 28321 | 1.57 |
| 10:32 ET | 24780 | 1.59 |
| 10:33 ET | 51761 | 1.6098 |
| 10:35 ET | 22093 | 1.61 |
| 10:37 ET | 4800 | 1.6033 |
| 10:39 ET | 4010 | 1.605 |
| 10:42 ET | 10320 | 1.601 |
| 10:44 ET | 2287 | 1.605 |
| 10:46 ET | 8180 | 1.6 |
| 10:48 ET | 22713 | 1.61 |
| 10:50 ET | 17159 | 1.605 |
| 10:51 ET | 16210 | 1.6 |
| 10:53 ET | 7758 | 1.6 |
| 10:55 ET | 97356 | 1.589 |
| 10:57 ET | 14243 | 1.585 |
| 11:00 ET | 11597 | 1.5924 |
| 11:02 ET | 2753 | 1.5969 |
| 11:04 ET | 1100 | 1.59 |
| 11:06 ET | 27362 | 1.5914 |
| 11:08 ET | 14838 | 1.59 |
| 11:09 ET | 1282 | 1.585 |
| 11:11 ET | 9542 | 1.58 |
| 11:13 ET | 11846 | 1.588 |
| 11:15 ET | 35076 | 1.595 |
| 11:18 ET | 2650 | 1.5999 |
| 11:20 ET | 12473 | 1.59 |
| 11:22 ET | 3100 | 1.595 |
| 11:24 ET | 8533 | 1.5905 |
| 11:26 ET | 8800 | 1.59 |
| 11:27 ET | 6534 | 1.59 |
| 11:29 ET | 4949 | 1.595 |
| 11:31 ET | 2710 | 1.595 |
| 11:33 ET | 5049 | 1.59 |
| 11:36 ET | 3992 | 1.59 |
| 11:38 ET | 3200 | 1.595 |
| 11:40 ET | 5158 | 1.59 |
| 11:42 ET | 3510 | 1.59 |
| 11:44 ET | 2900 | 1.59 |
| 11:45 ET | 30297 | 1.59 |
| 11:47 ET | 7993 | 1.58 |
| 11:49 ET | 6288 | 1.58 |
| 11:51 ET | 3202 | 1.5899 |
| 11:54 ET | 5326 | 1.5812 |
| 11:56 ET | 11064 | 1.585 |
| 11:58 ET | 19311 | 1.585 |
| 12:00 ET | 9024 | 1.585 |
| 12:02 ET | 3500 | 1.59 |
| 12:03 ET | 10693 | 1.585 |
| 12:05 ET | 7629 | 1.58 |
| 12:07 ET | 27216 | 1.585 |
| 12:09 ET | 7796 | 1.585 |
| 12:12 ET | 9554 | 1.5803 |
| 12:14 ET | 3947 | 1.585 |
| 12:16 ET | 113552 | 1.57 |
| 12:18 ET | 38966 | 1.55 |
| 12:20 ET | 21026 | 1.56 |
| 12:21 ET | 23233 | 1.56 |
| 12:23 ET | 9128 | 1.555 |
| 12:25 ET | 18079 | 1.56 |
| 12:27 ET | 16414 | 1.55 |
| 12:30 ET | 10850 | 1.55 |
| 12:32 ET | 6671 | 1.55 |
| 12:34 ET | 9113 | 1.5599 |
| 12:36 ET | 22868 | 1.555 |
| 12:38 ET | 12354 | 1.55 |
| 12:39 ET | 2000 | 1.555 |
| 12:41 ET | 94894 | 1.55 |
| 12:43 ET | 9496 | 1.54 |
| 12:45 ET | 26649 | 1.555 |
| 12:48 ET | 4207 | 1.555 |
| 12:50 ET | 2652 | 1.555 |
| 12:52 ET | 12082 | 1.555 |
| 12:54 ET | 2453 | 1.555 |
| 12:56 ET | 114114 | 1.58 |
| 12:57 ET | 3100 | 1.5831 |
| 12:59 ET | 5270 | 1.585 |
| 01:01 ET | 8094 | 1.585 |
| 01:03 ET | 1600 | 1.585 |
| 01:06 ET | 4620 | 1.585 |
| 01:08 ET | 19850 | 1.59 |
| 01:10 ET | 1000 | 1.585 |
| 01:12 ET | 1951 | 1.59 |
| 01:14 ET | 250 | 1.585 |
| 01:15 ET | 16724 | 1.5899 |
| 01:17 ET | 14524 | 1.585 |
| 01:19 ET | 7379 | 1.585 |
| 01:21 ET | 18048 | 1.5808 |
| 01:24 ET | 4500 | 1.585 |
| 01:26 ET | 1649 | 1.585 |
| 01:28 ET | 2640 | 1.585 |
| 01:30 ET | 10794 | 1.5899 |
| 01:32 ET | 4090 | 1.5899 |
| 01:33 ET | 25041 | 1.585 |
| 01:35 ET | 5544 | 1.595 |
| 01:37 ET | 2226 | 1.595 |
| 01:39 ET | 8350 | 1.595 |
| 01:42 ET | 17000 | 1.596 |
| 01:44 ET | 4446 | 1.59 |
| 01:46 ET | 7946 | 1.59 |
| 01:48 ET | 4412 | 1.59 |
| 01:50 ET | 11100 | 1.59 |
| 01:51 ET | 9783 | 1.59 |
| 01:53 ET | 8658 | 1.59 |
| 01:55 ET | 21100 | 1.595 |
| 01:57 ET | 101872 | 1.615 |
| 02:00 ET | 15678 | 1.606 |
| 02:02 ET | 6123 | 1.6003 |
| 02:04 ET | 24800 | 1.6 |
| 02:06 ET | 700 | 1.605 |
| 02:08 ET | 15359 | 1.6 |
| 02:09 ET | 8331 | 1.595 |
| 02:11 ET | 8700 | 1.595 |
| 02:13 ET | 6740 | 1.595 |
| 02:15 ET | 29606 | 1.61 |
| 02:18 ET | 27924 | 1.6184 |
| 02:20 ET | 14549 | 1.61 |
| 02:22 ET | 2961 | 1.605 |
| 02:24 ET | 5415 | 1.6 |
| 02:27 ET | 4200 | 1.6 |
| 02:29 ET | 8717 | 1.605 |
| 02:31 ET | 3100 | 1.6 |
| 02:33 ET | 27534 | 1.595 |
| 02:36 ET | 4844 | 1.595 |
| 02:38 ET | 6070 | 1.595 |
| 02:40 ET | 18928 | 1.6017 |
| 02:42 ET | 3426 | 1.605 |
| 02:44 ET | 23880 | 1.615 |
| 02:45 ET | 17587 | 1.61 |
| 02:47 ET | 28071 | 1.615 |
| 02:49 ET | 4800 | 1.62 |
| 02:51 ET | 4015 | 1.615 |
| 02:54 ET | 7135 | 1.61 |
| 02:56 ET | 44117 | 1.605 |
| 02:58 ET | 1700 | 1.6 |
| 03:00 ET | 3700 | 1.605 |
| 03:02 ET | 1230 | 1.61 |
| 03:03 ET | 1100 | 1.6099 |
| 03:05 ET | 3329 | 1.6082 |
| 03:07 ET | 4050 | 1.605 |
| 03:09 ET | 2468 | 1.605 |
| 03:12 ET | 3869 | 1.605 |
| 03:14 ET | 1581 | 1.605 |
| 03:16 ET | 1819 | 1.605 |
| 03:18 ET | 9034 | 1.6089 |
| 03:20 ET | 3430 | 1.6 |
| 03:21 ET | 6300 | 1.605 |
| 03:23 ET | 8847 | 1.605 |
| 03:25 ET | 5898 | 1.6042 |
| 03:27 ET | 5300 | 1.6 |
| 03:30 ET | 29447 | 1.6 |
| 03:32 ET | 5323 | 1.605 |
| 03:34 ET | 2652 | 1.6 |
| 03:36 ET | 10792 | 1.605 |
| 03:38 ET | 9895 | 1.6 |
| 03:39 ET | 8962 | 1.6008 |
| 03:41 ET | 3204 | 1.605 |
| 03:43 ET | 5600 | 1.6099 |
| 03:45 ET | 21158 | 1.605 |
| 03:48 ET | 9690 | 1.6 |
| 03:50 ET | 71434 | 1.595 |
| 03:52 ET | 13090 | 1.59 |
| 03:54 ET | 10983 | 1.5999 |
| 03:56 ET | 26155 | 1.59 |
| 03:57 ET | 27530 | 1.59 |
| 03:59 ET | 212109 | 1.59 |
Yesterday
ROSEN, A TOP RANKED LAW FIRM, Encourages Ocugen, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - OCGN, from 17 hours ago by Dow Jones
17 hours ago by Dow Jones*DJ Ocugen Announces Distribution of Series C Preferred Stk to Holders of Its Common Stk, from 17 hours ago by Dow Jones
17 hours ago by Dow JonesOcugen Announces Distribution of Series C Preferred Stock to Holders of its Common Stock, from 17 hours ago by Dow Jones
17 hours ago by Dow JonesOCUGEN (NASDAQ: OCGN) INVESTOR ALERT: Kaplan Fox & Kilsheimer LLP Reminds Ocugen Investors of a Class Action Lawsuit and June 10, 2024 Lead Plaintiff Deadline, from 18 hours ago by Dow Jones
18 hours ago by Dow JonesINVESTOR ACTION NOTICE: The Schall Law Firm Encourages Investors in Ocugen, Inc. with Losses In Excess of $500,000 to Contact the Firm, from 21 hours ago by Dow Jones
21 hours ago by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Ocugen Inc | 409.2M | -6.1x | --- |
LENZ Therapeutics Inc | 401.7M | -1.0x | --- |
Neurogene Inc | 418.1M | -1.1x | --- |
Replimune Group Inc | 393.5M | -2.0x | --- |
Solid Biosciences Inc | 393.4M | -2.1x | --- |
Lexeo Therapeutics Inc | 432.9M | -4.9x | --- |
Company Information
Ocugen, Inc. is a biopharmaceutical company. The Company is focused on discovering, developing, and commercializing gene and cell therapies, biologics, and vaccines that improve health for patients across the globe. Its technology pipeline includes modifier gene therapy platform, regenerative medicine cell therapy platform, and biologic therapies for retinal diseases. The Company is developing its modifier gene therapy platform, inclusive of OCU400, OCU410, and OCU410ST, for the treatment of multiple inherited retinal disease (IRDs), including retinitis pigmentosa (RP), Leber congenital amaurosis (LCA), Stargardt disease and multifactorial diseases such as dry age-related macular degeneration (dAMD) and geographic atrophy (GA). It is developing an inhalation-based mucosal vaccine platform based on a novel ChAd vector, which includes OCU500, a COVID-19 vaccine; OCU510, a seasonal quadrivalent flu vaccine; and OCU520, a combination quadrivalent seasonal flu and COVID-19 vaccine.
Contact Information
- Headquarters
- 11 GREAT VALLEY PARKWAYMALVERN, PA, United States 19355
- Phone
- 484-328-4701
- Fax
- 302-655-5049
Executives
- Chairman of the Board, Chief Executive Officer
- Shankar Musunuri
- Principal Financial Officer, Interim Chief Accounting Officer
- Michael Breininger
- Chief Marketing Officer
- Huma Qamar
- Chief Scientific Officer, Executive Officer, Head of Research, Development and Medical
- Arun Upadhyay
- Independent Director
- Kirsten Castillo
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $409.2M |
|---|---|
Revenue (TTM) | $6.0M |
Shares Outstanding | 257.3M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 3.57 |
EPS | $-0.26 |
Book Value | $0.16 |
P/E Ratio | -6.1x |
Price/Sales (TTM) | 67.8 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -1,085.67% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
